Skip to main content
SpringerLink
Log in

Molecular Testing of Nodules with a Suspicious or Malignant Cytologic Diagnosis in the Setting of Non-Invasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP)

  • Published:
Endocrine Pathology Aims and scope Submit manuscript

Abstract

Non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) is an indolent thyroid tumor characterized by frequent RAS mutations and an absence of the BRAF V600E mutation commonly seen in classical papillary thyroid carcinoma (cPTC). The ability to differentiate potential NIFTP/follicular variant of papillary thyroid carcinoma (FVPTC) from cPTC at the time of fine-needle aspiration (FNA) can facilitate conservative management of NIFTP. The aim of the current study was to investigate how molecular testing may add to cytologic assessment in the pre-operative differentiation of potential NIFTP/FVPTC and cPTC. We had previously evaluated cytologists’ ability to prospectively distinguish potential NIFTP/FVPTC from cPTC in a cohort of 56 consecutive FNAs diagnosed as malignant or suspicious for malignancy. We utilized this cohort to perform molecular analysis. Detected molecular abnormalities were stratified into two groups: (1) those supporting malignancy and (2) those supporting a diagnosis of potential NIFTP/FVPTC. The cytologists’ characterization of cases and the detected molecular alterations were correlated with the final histologic diagnoses. Molecular testing was performed in 52 (93%) of the 56 cases. For the 37 cases cytologists favored to be cPTC, 31 (84%) had a molecular result that supported malignancy (28 BRAF V600E mutations, 2 NTRK1 fusions, 1 AGK-BRAF fusion). For the 8 cases that were favored to be NIFTP/FVPTC by cytologists, 7 (88%) had a molecular result that supported conservative management (1 NRAS mutation, 6 wild-type result). Seven cases were designated as cytomorphologically indeterminate for NIFTP/FVPTC or cPTC, of which 6 (86%) had a molecular result that would have aided in the pre-operative assessment of potential NIFTP/FVPTC or cPTC/malignancy. These included 3 BRAF V600E mutations in nodules that were cPTC on resection, an HRAS mutation, and a wild-type result in the 2 nodules that were NIFTP, and a TERT promoter mutation along with an NRAS mutation in a poorly differentiated thyroid carcinoma. For nodules with an FNA diagnosis of suspicious for malignancy or malignant, cytologists can differentiate most cases of potential NIFTP/FVPTC from cPTC. However, molecular testing may be valuable for a subset of cases, especially those that are indeterminate for potential NIFTP/FVPTC versus cPTC based on cytologic features alone.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Nikiforov YE, Seethala RR, Tallini G et al. Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma: A Paradigm Shift to Reduce Overtreatment of Indolent Tumors. JAMA Oncol 2: 1023–1029, 2016.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Seethala RR, Baloch ZW, Barletta JA et al. Noninvasive follicular thyroid neoplasm with papillary-like nuclear features: a review for pathologists. Mod Pathol 31: 39–55, 2017.

  3. Afkhami M, Karunamurthy A, Chiosea S et al. Histopathologic and Clinical Characterization of Thyroid Tumors Carrying the BRAF(K601E) Mutation. Thyroid : official journal of the American Thyroid Association 26: 242–247, 2016.

    Article  CAS  Google Scholar 

  4. Howitt BE, Jia Y, Sholl LM, Barletta JA. Molecular alterations in partially-encapsulated or well-circumscribed follicular variant of papillary thyroid carcinoma. Thyroid : official journal of the American Thyroid Association 23: 1256–1262, 2013.

    Article  CAS  Google Scholar 

  5. Howitt BE, Paulson VA, Barletta JA. Absence of BRAF V600E in non-infiltrative, non-invasive follicular variant of papillary thyroid carcinoma. Histopathology 67: 579–582, 2015.

    Article  PubMed  Google Scholar 

  6. Paulson VA, Shivdasani P, Angell TE et al. Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features Accounts for More Than Half of "Carcinomas" Harboring RAS Mutations. Thyroid : official journal of the American Thyroid Association 27: 506–511, 2017.

    Article  CAS  Google Scholar 

  7. Rivera M, Ricarte-Filho J, Knauf J et al. Molecular genotyping of papillary thyroid carcinoma follicular variant according to its histological subtypes (encapsulated vs infiltrative) reveals distinct BRAF and RAS mutation patterns. Mod Pathol 23: 1191–1200, 2010.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Zhao L, Dias-Santagata D, Sadow PM, Faquin WC Cytological, molecular, and clinical features of noninvasive follicular thyroid neoplasm with papillary-like nuclear features versus invasive forms of follicular variant of papillary thyroid carcinoma. Cancer, 2017.

  9. Cancer Genome Atlas Research N Integrated genomic characterization of papillary thyroid carcinoma. Cell 159: 676–690, 2014.

    Article  Google Scholar 

  10. Xu B, Tuttle RM, Sabra MM, Ganly I, Ghossein R Primary Thyroid Carcinoma with Low-Risk Histology and Distant Metastases: Clinicopathologic and Molecular Characteristics. Thyroid : official journal of the American Thyroid Association 27: 632–640, 2017.

  11. Bizzarro T, Martini M, Capodimonti S et al. Young investigator challenge: The morphologic analysis of noninvasive follicular thyroid neoplasm with papillary-like nuclear features on liquid-based cytology: Some insights into their identification. Cancer 124: 699–710, 2016.

    CAS  Google Scholar 

  12. Brandler TC, Zhou F, Liu CZ et al. Can noninvasive follicular thyroid neoplasm with papillary-like nuclear features be distinguished from classic papillary thyroid carcinoma and follicular adenomas by fine-needle aspiration? Cancer Cytopathol 125: 378–388, 2017.

  13. Canberk S, Gunes P, Onenerk M et al. New Concept of the Encapsulated Follicular Variant of Papillary Thyroid Carcinoma and Its Impact on the Bethesda System for Reporting Thyroid Cytopathology: A Single-Institute Experience. Acta Cytol 60: 198–204, 2016.

    Article  PubMed  Google Scholar 

  14. Faquin WC, Wong LQ, Afrogheh AH et al. Impact of reclassifying noninvasive follicular variant of papillary thyroid carcinoma on the risk of malignancy in The Bethesda System for Reporting Thyroid Cytopathology. Cancer Cytopathol 124: 181–187, 2016.

    Article  PubMed  Google Scholar 

  15. Howitt BE, Chang S, Eszlinger M et al. Fine-needle aspiration diagnoses of noninvasive follicular variant of papillary thyroid carcinoma. Am J Clin Pathol 144: 850–857, 2015.

    Article  CAS  PubMed  Google Scholar 

  16. Rosario PW Ultrasonography and cytology as predictors of noninvasive follicular thyroid (NIFTP) neoplasm with papillary-like nuclear features: importance of the differential diagnosis with the invasive encapsulated follicular variant of papillary thyroid cancer. Clin Endocrinol (Oxf) 87: 635–636, 2017.

  17. Yang GCH, Fried KO, Scognamiglio T Sonographic and cytologic differences of NIFTP from infiltrative or invasive encapsulated follicular variant of papillary thyroid carcinoma: A Review of 179 Cases. Diagn Cytopathol 45: 533–541, 2017.

    Article  PubMed  Google Scholar 

  18. Maletta F, Massa F, Torregrossa L et al. Cytological features of "noninvasive follicular thyroid neoplasm with papillary-like nuclear features" and their correlation with tumor histology. Hum Pathol 54: 134–142, 2016.

    Article  CAS  PubMed  Google Scholar 

  19. Burch HB, Burman KD, Cooper DS, Hennessey JV, Vietor NO A 2015 Survey of Clinical Practice Patterns in the Management of Thyroid Nodules. J Clin Endocrinol Metab 101: 2853–2862, 2016.

    Article  CAS  PubMed  Google Scholar 

  20. Strickland KC, Vivero M, Jo VY et al. Preoperative Cytologic Diagnosis of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features: A Prospective Analysis. Thyroid : official journal of the American Thyroid Association 26: 1466–1471, 2016.

    Article  Google Scholar 

  21. Ali SZ, Cibas ES: The Bethesda System for Reporting Thyroid Cytopathology: Definitions, Criteria, and Explanatory Notes, New York: Springer, 2010.

    Book  Google Scholar 

  22. Eszlinger M, Lau L, Ghaznavi S et al. Molecular profiling of thyroid nodule fine-needle aspiration cytology. Nat Rev Endocrinol 13: 415–424, 2017.

  23. Ferraz C, Rehfeld C, Krogdahl A et al. Detection of PAX8/PPARG and RET/PTC rearrangements is feasible in routine air-dried fine needle aspiration smears. Thyroid : official journal of the American Thyroid Association 22: 1025–1030, 2012.

    Article  CAS  Google Scholar 

  24. Sholl LM, Do K, Shivdasani P et al. Institutional implementation of clinical tumor profiling on an unselected cancer population. JCI Insight 1: e87062, 2016.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Cordioli MI, Moraes L, Carvalheira G et al. AGK-BRAF gene fusion is a recurrent event in sporadic pediatric thyroid carcinoma. Cancer Med 5: 1535–1541, 2016.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Liu X, Bishop J, Shan Y et al. Highly prevalent TERT promoter mutations in aggressive thyroid cancers. Endocr Relat Cancer 20: 603–610, 2013.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Prasad ML, Vyas M, Horne MJ et al. NTRK fusion oncogenes in pediatric papillary thyroid carcinoma in northeast United States. Cancer 122: 1097–1107, 2016.

    Article  CAS  PubMed  Google Scholar 

  28. Xing M, Liu R, Liu X et al. BRAF V600E and TERT promoter mutations cooperatively identify the most aggressive papillary thyroid cancer with highest recurrence. J Clin Oncol 32: 2718–2726, 2014.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Bychkov A, Hirokawa M, Jung CK et al. Low Rate of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features in Asian Practice. Thyroid : official journal of the American Thyroid Association 27: 983–984, 2017.

    Article  Google Scholar 

  30. Hung YP, Barletta JA A user's guide to non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP). Histopathology 72: 53–69, 2018.

    Article  PubMed  Google Scholar 

  31. Ali SZ: The Bethesda system for reporting thyroid cytopathology : definitions, criteria, and explanatory notes.

  32. Mito JK, Alexander EK, Angell TE et al. A modified reporting approach for thyroid FNA in the NIFTP era: A 1-year institutional experience. Cancer 125: 854–864, 2017.

    CAS  Google Scholar 

  33. Ng D, Can NT, Ma ZV, van Zante A, Ljung B, Khanafshar E Cytomorphologic features of Noninvasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features (NIFTP): a comparison with infiltrative follicular variant of papillary thyroid carcinoma. J Basic Clinical Medicine 6: 51–56, 2017.

    Article  Google Scholar 

  34. Renshaw AA, Gould EW Incidence and significance of true papillae in thyroid fine needle aspiration. Diagn Cytopathol 45: 689–692, 2017.

    Article  PubMed  Google Scholar 

  35. Brown NA, Furtado LV, Betz BL et al. High prevalence of somatic MAP2K1 mutations in BRAF V600E-negative Langerhans cell histiocytosis. Blood 124: 1655–1658, 2014.

    Article  CAS  PubMed  Google Scholar 

  36. Chakraborty R, Hampton OA, Shen X et al. Mutually exclusive recurrent somatic mutations in MAP2K1 and BRAF support a central role for ERK activation in LCH pathogenesis. Blood 124: 3007–3015, 2014.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Nelson DS, van Halteren A, Quispel WT et al. MAP2K1 and MAP3K1 mutations in Langerhans cell histiocytosis. Genes Chromosomes Cancer 54: 361–368, 2015.

    Article  CAS  PubMed  Google Scholar 

  38. Nikolaev SI, Rimoldi D, Iseli C et al. Exome sequencing identifies recurrent somatic MAP2K1 and MAP2K2 mutations in melanoma. Nat Genet 44: 133–139, 2011.

    Article  PubMed  Google Scholar 

  39. Haugen BR, Alexander EK, Bible KC et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid : official journal of the American Thyroid Association 26: 1–133, 2016.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, Brigham and Women’s Hospital, Harvard Medical School, 75 Francis Street, Boston, MA, 02115, USA

    Kyle C. Strickland, Vickie Y. Jo, Alarice Lowe, Marina Vivero, Monica Hollowell, Xiaohua Qian, Tad Wieczorek, Christopher A. French, Lisa A. Teot, Edmund S. Cibas, Neal I. Lindeman, Jeffrey F. Krane & Justine A. Barletta

  2. Departments of Oncology, Pathology and Laboratory Medicine, Biochemistry and Molecular Biology, and Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada

    Markus Eszlinger

  3. Departments of Medicine, Oncology, Pathology and Laboratory Medicine, Biochemistry and Molecular Biology, and Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada

    Ralf Paschke

  4. Division of Endocrinology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA

    Trevor E. Angell, Erik K. Alexander & Ellen Marqusee

  5. Department of Surgery, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA

    Matthew A. Nehs

Authors
  1. Kyle C. Strickland
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Markus Eszlinger
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ralf Paschke
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Trevor E. Angell
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Erik K. Alexander
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Ellen Marqusee
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Matthew A. Nehs
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Vickie Y. Jo
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Alarice Lowe
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Marina Vivero
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Monica Hollowell
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Xiaohua Qian
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Tad Wieczorek
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Christopher A. French
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Lisa A. Teot
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. Edmund S. Cibas
    View author publications

    You can also search for this author in PubMed Google Scholar

  17. Neal I. Lindeman
    View author publications

    You can also search for this author in PubMed Google Scholar

  18. Jeffrey F. Krane
    View author publications

    You can also search for this author in PubMed Google Scholar

  19. Justine A. Barletta
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Justine A. Barletta.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Electronic supplementary material

ESM 1

(DOCX 13 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Strickland, K.C., Eszlinger, M., Paschke, R. et al. Molecular Testing of Nodules with a Suspicious or Malignant Cytologic Diagnosis in the Setting of Non-Invasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP). Endocr Pathol 29, 68–74 (2018). https://doi.org/10.1007/s12022-018-9515-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12022-018-9515-x

Keywords

Search

Navigation